Drug profile

The FDA adverse-event record for Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain

85 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain. See the species affected, top reactions, and outcomes below.

85
adverse-event reports
16.5%
death-coded share
Dog
most-reported species
23
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
85
Total Reports
14
Deaths Reported
16.5%
Death Rate

Active Ingredients

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain

Administration Routes

Subcutaneous

Species Affected

Dog 85

Most Affected Breeds

Retriever - Labrador 12
Chihuahua 9
Terrier - Yorkshire 8
Rottweiler 4
Beagle 3
Pinscher - Miniature 3
Weimaraner 3
Retriever - Golden 3
Terrier - Jack Russell 3
Boxer (German Boxer) 3

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 23
Vomiting 23
Diarrhoea 17
Other abnormal test result NOS 15
Elevated serum alkaline phosphatase (SAP) 10
Fever 9
Anorexia 9
Leucocytosis NOS 9
Death by euthanasia 8
Hypoalbuminaemia 8
Lack of efficacy - NOS 8
Decreased appetite 8

Outcome Breakdown

Ongoing
45 (50.6%)
Recovered/Normal
26 (29.2%)
Euthanized
8 (9.0%)
Died
6 (6.7%)
Outcome Unknown
4 (4.5%)

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain Adverse Event Insights

85 reports name Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain; 14 recorded a death outcome (16.5% of reported events, not a population-level mortality rate). Active ingredient: Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain. Administration route: Subcutaneous.

By species: Dog (85 reports). By breed: Retriever - Labrador (12), Chihuahua (9), Terrier - Yorkshire (8).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (23), Vomiting (23), Diarrhoea (17), Other abnormal test result NOS (15). Outcome, 89 coded reports: Ongoing leads at 50.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.